Invesco Dynamic Pharmaceuticals ETF (PJP)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Invesco Dynamic Pharmaceuticals ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Invesco Dynamic Pharmaceuticals ETF (PJP) has returned -0.44% so far this year and 21.16% over the past 12 months. Over the last ten years, PJP has returned 6.42% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Jun 23, 2005, PJP's average daily return is +0.05%, while the average monthly return is +0.98%. At this rate, your investment would double in approximately 5.9 years.

Historically, 60% of months were positive and 40% were negative. The best month was Apr 2020 with a return of +13.5%, while the worst month was Jan 2016 at -12.3%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, PJP closed higher 53% of trading days. The best single day was Oct 13, 2008 with a return of +10.2%, while the worst single day was Mar 16, 2020 at -9.9%.

Invesco Dynamic Pharmaceuticals ETF has an annualized alpha of 4.91%, beta of 0.75, and R² of 0.57 versus S&P 500 Index. Calculated based on daily prices since June 24, 2005.

• This ETF participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (89.78%) than losses (77.19%) — typical of diversified or defensive assets.
• This ETF generated an annualized alpha of 4.91% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.

PJP has an expense ratio of 0.58%, placing it in the medium range.

PJP ranks 58 for risk / return — on par with similar ETFs. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and compare them to a chosen benchmark (S&P 500 Index).

Invesco Dynamic Pharmaceuticals ETF provided a 1.02% dividend yield over the last twelve months, with an annual payout of $1.06 per share. The fund has been increasing its distributions for 6 consecutive years.

The table displays the monthly dividend distributions for Invesco Dynamic Pharmaceuticals ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Invesco Dynamic Pharmaceuticals ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Invesco Dynamic Pharmaceuticals ETF was 37.06%, occurring on Mar 23, 2020. Recovery took 206 trading sessions.

The current Invesco Dynamic Pharmaceuticals ETF drawdown is 5.83%.

The chart below shows the rolling one-month volatility.